Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Saved in:
Bibliographic Details
Title: Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy.
Authors: Sharma T; Department of Cardiology, Clinical Sciences (T.S., J.G.S., S.K., R.R., D.E.), Lund University, Lund, Sweden.; National Heart and Lung Institute, Imperial College London, United Kingdom (T.S., R.Y.K.)., Fall T; Molecular Epidemiology, Department of Medical Sciences (T.F., S.S.-B.), Uppsala University, Sweden., Sayols-Baixeras S; Molecular Epidemiology, Department of Medical Sciences (T.F., S.S.-B.), Uppsala University, Sweden.; Medical Epidemiology, Department of Surgical Sciences (S.S.-B.), Uppsala University, Sweden.; CIBER Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain (S.S.-B.)., Maehara A; New York-Presbyterian Hospital and Columbia University Irving Medical Center (A.M.).; Cardiovascular Research Foundation, New York, NY (A.M., M. Matsumura)., Maeng M; Department of Cardiology, Department of Clinical Medicine, Aarhus University Hospital (M. Maeng), Aarhus University, Denmark., Kjøller-Hansen L; Zealand University Hospital, Roskilde, Denmark (L.K.-H.)., Engstrøm T; Rigshospitalet, University of Copenhagen, Denmark (T.E.)., Ben-Yehuda O; University of California, San Diego (O.B.-Y., D.E.)., Matsumura M; Cardiovascular Research Foundation, New York, NY (A.M., M. Matsumura)., Fröbert O; Department of Biomedicine (O.F.), Aarhus University, Denmark.; Faculty of Health, Department of Clinical Medicine (O.F.), Aarhus University, Denmark.; Faculty of Health, Orebro University, Sweden (O.F.).; Steno Diabetes Center Aarhus (O.F.), Aarhus University Hospital, Denmark.; Department of Clinical Pharmacology (O.F.), Aarhus University Hospital, Denmark., Persson J; Department of Clinical Sciences, Danderyd University Hospital (J.P.), Karolinska Institutet, Stockholm, Sweden., Wiseth R; St. Olav's Hospital, Trondheim, Norway (R.W.)., Larsen AI; Department of Cardiology, Stavanger University Hospital, Norway (A.I.L.)., Smith JG; Department of Cardiology, Clinical Sciences (T.S., J.G.S., S.K., R.R., D.E.), Lund University, Lund, Sweden.; Wallenberg Center for Molecular Medicine and Lund University Diabetes Center (J.G.S.), Lund University, Lund, Sweden.; The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg University and the Department of Cardiology, Sahlgrenska University Hospital, Sweden (J.G.S., J.B.).; Science for Life Laboratory, Gothenburg University, Sweden (J.G.S.)., Engström G; Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden (G.E.)., Ärnlöv J; Department of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care (J.A.), Karolinska Institutet, Stockholm, Sweden.; School of Health and Welfare, Dalarna University, Falun, Sweden (J.A.).; Center for Clinical Research Dalarna, Falun, Sweden (J.A.)., Borén J; The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg University and the Department of Cardiology, Sahlgrenska University Hospital, Sweden (J.G.S., J.B.)., Khamis RY; National Heart and Lung Institute, Imperial College London, United Kingdom (T.S., R.Y.K.)., Tsimikas S; Division of Cardiovascular Medicine, Vascular Medicine Program, Sulpizio Cardiovascular Center, University of California, San Diego (S.T.)., Koul S; Department of Cardiology, Clinical Sciences (T.S., J.G.S., S.K., R.R., D.E.), Lund University, Lund, Sweden., Rylance R; Department of Cardiology, Clinical Sciences (T.S., J.G.S., S.K., R.R., D.E.), Lund University, Lund, Sweden., Ali ZA; St. Francis Hospital, Roslyn, NY (Z.A.A.)., James SK; Department of Medical Sciences and Uppsala Clinical Research Center (S.K.J.), Uppsala University, Sweden., Stone GW; Icahn School of Medicine at Mount Sinai, New York City, NY (G.W.S.)., Erlinge D; Department of Cardiology, Clinical Sciences (T.S., J.G.S., S.K., R.R., D.E.), Lund University, Lund, Sweden.; University of California, San Diego (O.B.-Y., D.E.).
Source: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2026 Aug; Vol. 46 (8), pp. e324430. Date of Electronic Publication: 2026 Jun 25.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505803 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4636 (Electronic) Linking ISSN: 10795642 NLM ISO Abbreviation: Arterioscler Thromb Vasc Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1524-4636
DOI:10.1161/ATVBAHA.125.324430